Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

378 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 378 results

Testing effectiveness (Phase 2)UnknownNCT00492687
What this trial is testing

Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
San Diego Pacific Oncology & Hematology Associates 80
Not applicableUnknownNCT00449514
What this trial is testing

Tamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous Cycle

Who this might be right for
Infertility
Shaare Zedek Medical Center 100
Early research (Phase 1)Study completedNCT01192308
What this trial is testing

PharmacoKINEtics of TAMoxifen and Its Metabolites in Breast Cancer Patients: the Influence of a Dose Increase in Phenotypic Poor Metabolizers of CYP2D6 (KINETAM)

Who this might be right for
Breast Cancer
Radboud University Medical Center 42
Large-scale testing (Phase 3)Study completedNCT00784940
What this trial is testing

ATAC - Bone Density Sub-Protocol

Who this might be right for
Bone Density
AstraZeneca 308
Early research (Phase 1)Study completedNCT02835079
What this trial is testing

Treatment Effect of Tamoxifen on Patients With DMD

Who this might be right for
Duchenne Muscular Dystrophy
Hadassah Medical Organization 19
Large-scale testing (Phase 3)Study completedNCT00072462
What this trial is testing

Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ

Who this might be right for
Breast Cancer
Queen Mary University of London 2,980
Large-scale testing (Phase 3)Study completedNCT00003140
What this trial is testing

Letrozole After Tamoxifen in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 5,187
Not applicableStudy completedNCT00830973
What this trial is testing

The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer

Who this might be right for
Breast NeoplasmsTamoxifen
Medco Health Solutions, Inc. 184
Not applicableUnknownNCT01181518
What this trial is testing

Tamoxifen Pharmacogenetics in Asian Breast Cancer Women

Who this might be right for
Poisoning by, Adverse Effect of and Underdosing of Tamoxifen
Inje University 1,000
Testing effectiveness (Phase 2)Study completedNCT00038103
What this trial is testing

Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen

Who this might be right for
Breast Neoplasms
Pfizer 111
Testing effectiveness (Phase 2)Study completedNCT00903162
What this trial is testing

Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 17
Large-scale testing (Phase 3)Study completedNCT01638247
What this trial is testing

Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients

Who this might be right for
Male Breast Cancer
GBG Forschungs GmbH 56
Very early researchStudy completedNCT00727948
What this trial is testing

The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy

Who this might be right for
Breast CancerAngiogenesis
University of Vermont 11
Not applicableStudy completedNCT01050634
What this trial is testing

Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)

Who this might be right for
Post Menopausal Women With Early Breast Cancer
Pfizer 980
Not applicableUnknownNCT00126464
What this trial is testing

Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast

Who this might be right for
Breast Cancer
Cedars-Sinai Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT03870399
What this trial is testing

Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression

Who this might be right for
Neuroendocrine TumorsProgesterone Receptor Positive TumorEstrogen Receptor Positive Tumor
AC Camargo Cancer Center 23
Not applicableStudy completedNCT00943527
What this trial is testing

Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast

Who this might be right for
Breast Cancer
Mayo Clinic 110
Large-scale testing (Phase 3)Looking for participantsNCT05774951
What this trial is testing

Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Who this might be right for
Breast Cancer, Early Breast Cancer
AstraZeneca 4,300
Large-scale testing (Phase 3)Active Not RecruitingNCT00382070
What this trial is testing

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 3,966
Testing effectiveness (Phase 2)Study completedNCT03528902
What this trial is testing

Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension

Who this might be right for
HypertensionPulmonary Arterial HypertensionFamilial Primary Pulmonary Hypertension+6 more
Vanderbilt University Medical Center 18
Load More Results